CD40 agonist improves the therapeutic efficacy of irreversible electroporation ablation for metastatic melanoma by promoting unexpected CD8+CD103+ cDC1 and TRM cell responses

Zhaojia Wu(University of Saskatchewan), Jim Xiang(Beijing Institute of Technology)
Cancer Immunology Immunotherapy
November 18, 2025
Cited by 0


Related Papers